Buy Suven Life Sciences, target Rs 210: Manas Jaiswal

Manas Jaiswal of manasjaiswal.com has a buy call on Suven Life Sciences Ltd. with a target price of Rs 210.0 .The current market price of Suven Life Sciences Ltd. is Rs 197.25 Time period given by analyst is Intra Day when Suven Life Sciences Ltd. price can reach defined target. Manas Jaiswal maintains stoploss at Rs 189.

Suven Life Sciences Ltd., incorporated in the year 1989, is a midcap company (with a market cap of ₹ 2510.65 Cr.) operating in Pharmaceuticals and health care sector.

Suven Life Sciences Ltd. key Products/Revenue Segments include Intermediate which contributed ₹ 431.53 Cr to Sales Value (86.38 % of Total Sales), Technical & Other Services Rendered which contributed ₹ 24.58 Cr to Sales Value (4.92 % of Total Sales), Sale of services which contributed ₹ 18.81 Cr to Sales Value (3.76 % of Total Sales), Job Work which contributed ₹ 18.28 Cr to Sales Value (3.65 % of Total Sales), Bulk Drugs which contributed ₹ 17.06 Cr to Sales Value (3.41 % of Total Sales), Royalty Income which contributed ₹ 13.60 Cr to Sales Value (2.72 % of Total Sales), Processing Charges which contributed ₹ 7.84 Cr to Sales Value (1.56 % of Total Sales), Recovery Units which contributed ₹ .24 Cr to Sales Value (0.04 % of Total Sales)for the year ending 31-Mar-2016.

For the quarter ended 31-12-2016, the company has reported a Standalone sales of ₹ 115.39 Cr., down -.13% from last quarter Sales of ₹ 115.55 Cr. and up 2.57% from last year same quarter Sales of ₹ 112.50 Cr. Company has reported net profit after tax of ₹ 24.27 Cr. in latest quarter. The company’s CEO is Mr.Venkateswarlu Jasti. It's Board of Directors include Mr.K Hanumantha Rao, Mr.P Subba Rao, Dr.K V Raghavan, Dr.M R Naidu, Mr.D G Prasad, Mr.M Gopalakrishna, Mr.Venkateswarlu Jasti, Mrs.Sudha Rani Jasti, Prof.Seyed E Hasnain, Mr.K Hanumantha Rao. Company has its registered office at SDE Serene Chambers,, Road No. 5,, Banjara Hills, Hyderabad, 500034, Andhra Pradesh. Company has Karvy & Co. as its auditors. As on 31-03-2017, the company has a total of 127,282,478 shares outstanding.